CVRx, Inc. (CVRX) has 56 open-market insider trades by 17 insiders since 2007. Over the last six months insiders net bought $73K. The most active filer is Mudit K. Jain, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Glaxosmithkline PLC | 10% Owner | — | 2 | $5.0M | 2021-07-02 |
| Geoffrey B. Pardo | Dir | — | 2 | $5.0M | 2021-07-02 |
| NEA Partners 10 L P | 10% Owner | — | 2 | $4.5M | 2021-07-02 |
| Mudit K. Jain | Dir | — | 8 | $4.4M | 2026-06-01 |
| NEW Enterprise Associates 10 L P | 10% Owner | — | 1 | $4.1M | 2021-07-02 |
| Kirk G. Nielsen | Dir | — | 8 | $2.7M | 2026-06-01 |
| Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | — | 4 | $857K | 2025-11-26 |
| John M. Nehra | Dir | — | 2 | $508K | 2021-07-02 |
| Kevin Hykes | PRES & CEO | — | 3 | $336K | 2026-03-02 |
| Paul Verrastro | — | — | 7 | $172K | 2026-03-02 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Brent Binkowski | COO | Buy | $76K | 2026-08-13 |
| Brent Binkowski | COO | Sell | $3K | 2026-08-12 |
| Jared Oasheim | CFO | Sell | $14K | 2026-03-02 |
| Robert Allen John | Chief Revenue Officer | Sell | $31K | 2026-03-02 |
| Philip B. Adamson | Chief Medical Officer | Sell | $10K | 2026-03-02 |
| Kevin Hykes | PRES & CEO | Sell | $61K | 2026-03-02 |
Companies that share insiders with CVRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Sell | $10K | 2026-03-02 |
| Mudit K. Jain | Director | Buy | $298K | 2026-02-20 |
| Mudit K. Jain | Director | Buy | $3K | 2026-02-18 |
| & Johnson Johnson | 10% | Sell | $64K | 2025-11-26 |
| Johnson & Johnson Innovation - JJDC, Inc. | 10% | Sell | $224K | 2025-11-25 |
| & Johnson Johnson | 10% | Sell | $27K | 2025-11-21 |
| & Johnson Johnson | 10% | Sell | $10K | 2025-11-12 |
| Johnson & Johnson Innovation - JJDC, Inc. | 10% | Sell | $536K | 2025-11-06 |
| Kirk G. Nielsen | Director | Buy | $60K | 2025-05-15 |